1. "2022"
Formats
  1. Journal Article (2449)
  2. Meeting Abstract (2196)
  3. Review (615)
  4. Editorial (363)
  5. Book Section (139)
  6. Correspondence (117)
  7. Guidelines (112)
  8. Research Letter (82)
  9. Miscellaneous (60)
  10. Conference Paper (29)
  11. Book Whole (6)
Groups
  1. Department of Medicine (2621)
  2. Solid Tumor Oncology Division (1573)
  3. Sloan Kettering Institute Postdocs (1364)
  4. GSK Faculty (1152)
  5. Surgery (1036)
  6. Hematologic Malignancies, Division of (964)

More Groups

People
  1. Miguel-Angel Perales (95)
  2. Alexander Drilon (85)
  3. Saad Usmani (83)
  4. Sergio Giralt (77)
  5. Marc Ladanyi (72)
  6. Gilles Salles (69)

More People

Years
  1. 2022 (6168)
Publications
  1. Journal of Clinical Oncology (520)
  2. Blood (319)
  3. Cancer Research (191)
  4. Annals of Oncology (158)
  5. Annals of Surgical Oncology (134)
  6. International Journal of Radiation Oncology, Biology, Physics (132)

More Publications

Publishers
  1. Elsevier Inc. (794)
  2. American Society of Clinical Oncology (583)
  3. Springer (440)
  4. Nature Publishing Group (379)
  5. American Society of Hematology (369)
  6. Oxford University Press (360)

More Publishers

Results (6168)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Largest evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated non-small cell lung cancer (NSCLC) and colorectal cancer (CRC): Plasma biomarker analysis of CodeBreaK100
    Meeting Abstract

    Li, B. T.; Velcheti, V.; Price, T. J.; Hong, D. S.; Fakih, M.; Kim, D. W.; Falchook, G. S.; Delord, J. P.; Dy, G. K.; Ramalingam, S. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Electronic research consents for complex early-phase I-II clinical trials integrated with telemedicine visits compared with in-person encounters
    Meeting Abstract

    Buckley, M. T.; O'Shea, M.; Lipitz-Snyderman, A.; Kuperman, G.; Shah, S.; Redelman-Sidi, Y.; Lengfellner, J. M.; Terzulli, S. L.; Houston, C.; Sabbatini, P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • ROCC/GOG-3043: A randomized non-inferiority trial of robotic versus open radical hysterectomy for early-stage cervical cancer
    Meeting Abstract

    Bixel, K. L.; Leitao, M. M.; Chase, D. M.; Quick, A.; Lim, P. C.; Eskander, R. N.; Gotlieb, W. H.; LoCoco, S.; Martino, M. A.; McCormick, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • COVID-19 in patients with gynecologic cancer: A preliminary report from the COVID-19 and Cancer Consortium (CCC19)
    Meeting Abstract

    Beeghly-Fadiel, A.; Prescott, L. S.; Ruiz-Garcia, E.; Hwang, C.; Heilman, H.; McKay, R. R.; Saliby, R. M.; Lau, S.; Nagaraj, G.; Puc, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors
    Meeting Abstract

    Bedard, P. L.; Hernando-Calvo, A.; Carvajal, R. D.; Morris, V. K.; Paik, P. K.; Zandberg, D. P.; Kaczmar, J. M.; Niculescu, L.; Bohr, D.; Reiners, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Patient preferences for second-line treatment options in diffuse large B-cell lymphoma: A discrete choice experiment
    Meeting Abstract

    Birch, K.; Chiu, K.; Baumgardner, J.; Snider, J.; Wade, S. W.; Shah, G. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A randomized trial on pelvic lymph node dissection versus no lymph node dissection at radical prostatectomy: Report of a trial in progress
    Meeting Abstract

    Benfante, N.; Carroll, E.; Carruthers, J.; Donahue, T. F.; Eastham, J. A.; Ehdaie, B.; Goh, A. C.; Laudone, V. P.; Pietzak, E. J.; Smith, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Banerjee, S. N.; Monk, B. J.; Van Nieuwenhuysen, E.; Moore, K. N.; Oaknin, A.; Fabbro, M.; Colombo, N.; O'Malley, D. M.; Coleman, R. L.; Oza, A. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term safety of inavolisib (GDC-0077) in an ongoing phase 1/1b study evaluating monotherapy and in combination (combo) with palbociclib and/or endocrine therapy in patients (pts) with PIK3CA-mutated, hormone receptor-positive/HER2-negative (HR+/ HER2-) metastatic breast cancer (BC)
    Meeting Abstract

    Bedard, P. L.; Accordino, M. K.; Cervantes, A.; Gambardella, V.; Hamilton, E. P.; Italiano, A.; Juric, D.; Kalinsky, K.; Krop, I. E.; Oliveira, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save